Neogen (NEOG) Competitors

Neogen (NASDAQ:NEOG) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

Do analysts prefer NEOG or ICUI?

Neogen presently has a consensus target price of $9.00, indicating a potential upside of 45.16%. ICU Medical has a consensus target price of $192.67, indicating a potential upside of 42.80%. Given Neogen's higher possible upside, equities analysts plainly believe Neogen is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
ICU Medical	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00

Does the MarketBeat Community prefer NEOG or ICUI?

ICU Medical received 68 more outperform votes than Neogen when rated by MarketBeat users. Likewise, 64.21% of users gave ICU Medical an outperform vote while only 56.46% of users gave Neogen an outperform vote.

Company	Underperform	Outperform
Neogen	Outperform Votes 332 56.46%	Underperform Votes 256 43.54%
ICU Medical	Outperform Votes 400 64.21%	Underperform Votes 223 35.79%

Do institutionals and insiders hold more shares of NEOG or ICUI?

96.7% of Neogen shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 1.1% of Neogen shares are owned by insiders. Comparatively, 1.5% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, NEOG or ICUI?

Neogen has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.

Which has higher earnings and valuation, NEOG or ICUI?

Neogen has higher earnings, but lower revenue than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$906.00M	1.49	-$9.42M	-$2.23	-2.78
ICU Medical	$2.42B	1.37	-$29.66M	-$3.83	-35.23

Does the media prefer NEOG or ICUI?

In the previous week, ICU Medical had 9 more articles in the media than Neogen. MarketBeat recorded 20 mentions for ICU Medical and 11 mentions for Neogen. Neogen's average media sentiment score of 0.80 beat ICU Medical's score of 0.39 indicating that Neogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ICU Medical	11 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is NEOG or ICUI more profitable?

ICU Medical has a net margin of -4.74% compared to Neogen's net margin of -52.12%. ICU Medical's return on equity of 5.05% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-52.12%	2.89%	1.98%
ICU Medical	-4.74%	5.05%	2.42%

Summary

ICU Medical beats Neogen on 11 of the 19 factors compared between the two stocks.